Formulating Poorly Water Soluble Drugs (Paperback, Softcover reprint of the original 2nd ed. 2016)


The objective of this volume is to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientist's approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound's physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at minimum a working knowledge of each of the abovementioned facets and detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop

R4,897

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles48970
Mobicred@R459pm x 12* Mobicred Info
Free Delivery
Delivery AdviceShips in 10 - 15 working days


Toggle WishListAdd to wish list
Review this Item

Product Description

The objective of this volume is to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientist's approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound's physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at minimum a working knowledge of each of the abovementioned facets and detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Springer International Publishing AG

Country of origin

Switzerland

Series

AAPS Advances in the Pharmaceutical Sciences Series, 22

Release date

July 2018

Availability

Expected to ship within 10 - 15 working days

Editors

, ,

Dimensions

235 x 155 x 40mm (L x W x T)

Format

Paperback

Pages

779

Edition

Softcover reprint of the original 2nd ed. 2016

ISBN-13

978-3-319-82618-9

Barcode

9783319826189

Categories

LSN

3-319-82618-2



Trending On Loot